ClearPoint Neuro Inc. Common Stock (CLPT)
Stock · NASDAQ · Health Care
$9.08as of 10/16/2026
Price chart
Active signals
CLPT Signal Track Record
How signals performed across all stocks →What CLPT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 38 | -3.1% | 42% | September 29, 2026 |
| Bollinger Band Breakout | 24 | -1.2% | 50% | August 25, 2026 |
| Bollinger Band Breakdown | 19 | +0.9% | 53% | September 29, 2026 |
| 200-Day Moving Average TouchActive now | 14 | -1.1% | 29% | September 10, 2026 |
| Any 20-session window (baseline) | -2.1% | 44% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CLPT
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 160
- Website
- www.clearpointneuro.com/
Fundamentals
- 1-day range
- $9$9.6
- Market cap
- $408.45M
- P/E (trailing)
- —
- P/E (forward)
- -7.59
- EPS (trailing)
- $-1.18
- Dividend yield
- —
- Beta
- 1.30
- Avg. volume
- 664.3K
- Dividend pay date
- July 27, 2016
How ClearPoint Neuro Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 17, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
ClearPoint Neuro Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CLPTClearPoint Neuro Inc. Common Stock$9.07▼ 5.91%Market cap $408.45MP/E —$8.27$28.1
- MOBIMobia Medical Inc. Common Stock$8.09▼ 2.65%Market cap $409.63MP/E —$8.16$15.29
- OFIXOrthofix Medical Inc. Common Stock (DE)$9.38▼ 2.19%Market cap $428.47MP/E —$8.5$16.99
- SGHTSight Sciences Inc. Common Stock$8.28▼ 5.91%Market cap $385.77MP/E —$3.34$9.71
- CARLCarlsmed Inc. Common Stock$13.41▼ 3.87%Market cap $372.43MP/E —$8.5$17.23
- SIShoulder Innovations Inc. Common Stock$18.09▼ 1.52%Market cap $465.16MP/E —$10.92$24.6
- CERSCerus Corporation Common Stock$2.18▼ 3.54%Market cap $467.54MP/E —$1.38$3.47
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CLPT ClearPoint Neuro Inc. Common Stock | $408.45M | — | $9.07 | ▼ 5.91% | $8.27$28.1 |
| MOBI Mobia Medical Inc. Common Stock | $409.63M | — | $8.09 | ▼ 2.65% | $8.16$15.29 |
| OFIX Orthofix Medical Inc. Common Stock (DE) | $428.47M | — | $9.38 | ▼ 2.19% | $8.5$16.99 |
| SGHT Sight Sciences Inc. Common Stock | $385.77M | — | $8.28 | ▼ 5.91% | $3.34$9.71 |
| CARL Carlsmed Inc. Common Stock | $372.43M | — | $13.41 | ▼ 3.87% | $8.5$17.23 |
| SI Shoulder Innovations Inc. Common Stock | $465.16M | — | $18.09 | ▼ 1.52% | $10.92$24.6 |
| CERS Cerus Corporation Common Stock | $467.54M | — | $2.18 | ▼ 3.54% | $1.38$3.47 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue EstimatesYahoo · 10/8/2026
- Cedar Grove Capital Q3 2026 Portfolio UpdateSeekingAlpha · 10/7/2026
- ClearPoint Neuro: My Speculative Buy Didn't Pan Out, Moving To HoldSeekingAlpha · 10/1/2026
- ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial UpdateYahoo · 9/29/2026
- These stocks that are showing activity before the opening bell on Tuesday.ChartMill · 9/29/2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga · 9/29/2026
- Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?Yahoo · 9/14/2026
Insider Activity
Insider Actions →- Richards Timothy T. · October 1, 2026 · Grant319 @ $12.21
- R. John Fletcher · October 1, 2026 · Grant993 @ $12.21
- BURNETT JOSEPH · September 2, 2026 · Option Exercise12.5K @ $3.47
- Richards Timothy T. · July 1, 2026 · Grant222 @ $17.84
- R. John Fletcher · July 1, 2026 · Grant662 @ $17.84
- STIGALL L. JEREMY · June 30, 2026 · Grant1.8K @ $11.93
- D'Alessandro Danilo · June 30, 2026 · Grant1.1K @ $11.93
- BURNETT JOSEPH · June 30, 2026 · Grant1.4K @ $11.93
- BURNETT JOSEPH · June 29, 2026 · Option Exercise20.0K @ $2.5
- BURNETT JOSEPH · June 29, 2026 · Sale20.0K @ $19.38
- BURNETT JOSEPH · June 17, 2026 · Option Exercise60.0K @ $2.5
- BURNETT JOSEPH · June 17, 2026 · Sale1.8K @ $17.94
- BURNETT JOSEPH · June 17, 2026 · Sale60.0K @ $17.79
- Richards Timothy T. · June 4, 2026 · Option Exercise500 @ $10
- Richards Timothy T. · June 4, 2026 · Tax Withholding376 @ $13.3
Institutional Ownership
March 31, 2026
- Total shares held
- 13.00M
- Total value held
- $114.67M
- Institutional holders
- 117
- Unknown2.08M
- Unknown1.90M
- Unknown1.24M
- Unknown705.7K
- Unknown679.8K
- Unknown486.8K
- Unknown463.6K
- Unknown451.5K
- Unknown432.4K
- Unknown372.4K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
CLPT Featured in Pre-Market Movers
ClearPoint Neuro (CLPT) was highlighted in pre-market lists for Tuesday, indicating notable trading activity before the open. The stock is currently trading near its 52-week low of $8.27 and has shown a volume spike. While analyst targets remain significantly higher at an average of $23.50, the recent price action suggests heightened volatility and interest from traders.
CLPT Featured in Pre-Market Movers. ClearPoint Neuro (CLPT) was highlighted in pre-market lists for Tuesday, indicating notable trading activity before the open. The stock is currently trading near its 52-week low of $8.27 and has shown a volume spike. While analyst targets remain significantly higher at an average of $23.50, the recent price action suggests heightened volatility and interest from traders.